相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。Randomised trial of external-beam radiotherapy alone or with high-dose-rate brachytherapy for prostate cancer: Mature 12-year results
Peter J. Hoskin et al.
RADIOTHERAPY AND ONCOLOGY (2021)
Intraprostatic calcification and biochemical recurrence in men treated with cesium-131 prostate brachytherapy
Michael D. Schad et al.
BRACHYTHERAPY (2021)
External Beam Radiation Therapy (EBRT) and High-Dose-Rate (HDR) Brachytherapy for Intermediate and High-Risk Prostate Cancer: The Impact of EBRT Volume
Hannah Tharmalingam et al.
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS (2020)
Single dose high-dose rate (HDR) brachytherapy (BT) as monotherapy for localised prostate cancer: Early results of a UK national cohort study
Hannah Tharmalingam et al.
RADIOTHERAPY AND ONCOLOGY (2020)
Prostate high dose -rate brachytherapy as monotherapy for low and intermediate risk prostate cancer: Efficacy results from a randomized phase II clinical trial of one fraction of 19 Gy or two fractions of 13.5 Gy
Gerard Morton et al.
RADIOTHERAPY AND ONCOLOGY (2020)
GEC-ESTRO/ACROP recommendations for quality assurance of ultrasound imaging in brachytherapy
Frank-Andre Siebert et al.
RADIOTHERAPY AND ONCOLOGY (2020)
Does ADT benefit unfavourable intermediate risk prostate cancer patients treated with brachytherapy boost and external beam radiotherapy? A propensity-score matched analysis
Lucas C. Mendez et al.
RADIOTHERAPY AND ONCOLOGY (2020)
In vivo dosimetry in brachytherapy: Requirements and future directions for research, development, and clinical practice
Gabriel P. Fonseca et al.
PHYSICS & IMAGING IN RADIATION ONCOLOGY (2020)
A history of transurethral resection of the prostate should not be a contra-indication for low-dose-rate 125I prostate brachytherapy: results of a prospective Uro-GEC phase-II trial
Carl Salembier et al.
JOURNAL OF CONTEMPORARY BRACHYTHERAPY (2020)
Dose Escalation for Prostate Adenocarcinoma: A Long-Term Update on the Outcomes of a Phase 3, Single Institution Randomized Clinical Trial
Dario Pasalic et al.
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS (2019)
GEC-ESTRO ACROP recommendations on calibration and traceability of LE-LDR photon-emitting brachytherapy sources at the hospital level
Jose Perez-Calatayud et al.
RADIOTHERAPY AND ONCOLOGY (2019)
MRI assisted focal boost integrated with HDR monotherapy study in low and intermediate risk prostate cancer (MARS): Results from a phase II clinical trial
Yasir Alayed et al.
RADIOTHERAPY AND ONCOLOGY (2019)
Results of 15 Gy HDR-BT boost plus EBRT in intermediate-risk prostate cancer: Analysis of over 500 patients
K. Martell et al.
RADIOTHERAPY AND ONCOLOGY (2019)
Comparative Effectiveness of Radical Prostatectomy Versus External Beam Radiation Therapy Plus Brachytherapy in Patients with High-risk Localized Prostate Cancer
Sebastian Berg et al.
EUROPEAN UROLOGY (2019)
Radical Prostatectomy, External Beam Radiotherapy, or External Beam Radiotherapy With Brachytherapy Boost and Disease Progression and Mortality in Patients With Gleason Score 9-10 Prostate Cancer
Amar U. Kishan et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2018)
Effect of Standard vs Dose-Escalated Radiation Therapy for Patients With Intermediate-Risk Prostate Cancer The NRG Oncology RTOG 0126 Randomized Clinical Trial
Jeff M. Michalski et al.
JAMA ONCOLOGY (2018)
Long-term outcomes analysis of low-dose-rate brachytherapy in clinically T3 high-risk prostate cancer
Manuj Agarwal et al.
BRACHYTHERAPY (2018)
Brachytherapy versus external beam radiotherapy boost for prostate cancer: Systematic review with meta-analysis of randomized trials
Daniel Lam Cham Kee et al.
CANCER TREATMENT REVIEWS (2018)
Long-term oncological outcomes and toxicity in 597 men aged 60years at time of low-dose-rate brachytherapy for localised prostate cancer
Stephen E. M. Langley et al.
BJU INTERNATIONAL (2018)
Quality of Life Outcomes after Primary Treatment for Clinically Localised Prostate Cancer: A Systematic Review
Michael Lardas et al.
EUROPEAN UROLOGY (2017)
Long-Term Results of a Randomized Trial Comparing Iridium Implant Plus External Beam Radiation Therapy With External Beam Radiation Therapy Alone in Node-Negative Locally Advanced Cancer of the Prostate
Ian S. Dayes et al.
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS (2017)
A Comparison Between Low-Dose-Rate Brachytherapy With or Without Androgen Deprivation, External Beam Radiation Therapy With or Without Androgen Deprivation, and Radical Prostatectomy With or Without Adjuvant or Salvage Radiation Therapy for High-Risk Prostate Cancer
Jay P. Ciezki et al.
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS (2017)
High-dose-rate brachytherapy as salvage modality for locally recurrent prostate cancer after definitive radiotherapy
Georgios Chatzikonstantinou et al.
STRAHLENTHERAPIE UND ONKOLOGIE (2017)
American Brachytherapy Society Task Group Report: Use of androgen deprivation therapy with prostate brachytherapy-A systematic literature review
M. Keyes et al.
BRACHYTHERAPY (2017)
Randomized non-inferiority trial of Bicalutamide and Dutasteride versus LHRH agonists for prostate volume reduction prior to I-125 permanent implant brachytherapy for prostate cancer
Marc Gaudet et al.
RADIOTHERAPY AND ONCOLOGY (2016)
Modelling second malignancy risks from low dose rate and high dose rate brachytherapy as monotherapy for localised prostate cancer
Louise Murray et al.
RADIOTHERAPY AND ONCOLOGY (2016)
A Delphi consensus study on salvage brachytherapy for prostate cancer relapse after radiotherapy, a Uro-GEC study
Emmie Kaljouw et al.
RADIOTHERAPY AND ONCOLOGY (2016)
High-dose-rate interstitial brachytherapy as monotherapy in one fraction for the treatment of favorable stage prostate cancer: Toxicity and long-term biochemical results
Pedro J. Prada et al.
RADIOTHERAPY AND ONCOLOGY (2016)
Focal partial salvage low-dose-rate brachytherapy for local recurrent prostate cancer after permanent prostate brachytherapy with a review of the literature
Hiroaki Kunogi et al.
JOURNAL OF CONTEMPORARY BRACHYTHERAPY (2016)
Comparison of focal boost high dose rate prostate brachytherapy optimisation methods
Josh Mason et al.
RADIOTHERAPY AND ONCOLOGY (2015)
Introduction of inverse dose optimization for ultrasound-based high-dose-rate boost brachytherapy: How we do it in Kiel
Frank-Andre Siebert et al.
BRACHYTHERAPY (2014)
Hormone and Radiotherapy versus Hormone or Radiotherapy Alone for Non-metastatic Prostate Cancer: A Systematic Review with Meta-analyses
M. Schmidt-Hansen et al.
CLINICAL ONCOLOGY (2014)
Second primary cancers after radiation for prostate cancer: A systematic review of the clinical data and impact of treatment technique
Louise Murray et al.
RADIOTHERAPY AND ONCOLOGY (2014)
Prostate brachytherapy in men with gland volume of 100 cc or greater: Technique, cancer control, and morbidity
Nelson N. Stone et al.
BRACHYTHERAPY (2013)
A New Risk Classification System for Therapeutic Decision Making with Intermediate-risk Prostate Cancer Patients Undergoing Dose-escalated External-beam Radiation Therapy
Zachary S. Zumsteg et al.
EUROPEAN UROLOGY (2013)
The Influence of Prostate Volume on Outcome After High-Dose-Rate Brachytherapy Alone for Localized Prostate Cancer
Hien Le et al.
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS (2013)
In vivo dosimetry in brachytherapy
Kari Tanderup et al.
MEDICAL PHYSICS (2013)
GEC/ESTRO recommendations on high dose rate afterloading brachytherapy for localised prostate cancer: An update
Peter J. Hoskin et al.
RADIOTHERAPY AND ONCOLOGY (2013)
Prospective multi-center dosimetry study of low-dose Iodine-125 prostate brachytherapy performed after transurethral resection
Carl Salembier et al.
JOURNAL OF CONTEMPORARY BRACHYTHERAPY (2013)
American Brachytherapy Society consensus guidelines for transrectal ultrasound-guided permanent prostate brachytherapy
Brian J. Davis et al.
BRACHYTHERAPY (2012)
HIGH-DOSE-RATE BRACHYTHERAPY ALONE FOR LOCALIZED PROSTATE CANCER IN PATIENTS AT MODERATE OR HIGH RISK OF BIOCHEMICAL RECURRENCE
Peter Hoskin et al.
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS (2012)
Prostate post-implant dosimetry: Interobserver variability in seed localisation, contouring and fusion
Marisol De Brabandere et al.
RADIOTHERAPY AND ONCOLOGY (2012)
Randomised trial of external beam radiotherapy alone or combined with high-dose-rate brachytherapy boost for localised prostate cancer
Peter J. Hoskin et al.
RADIOTHERAPY AND ONCOLOGY (2012)
Long term results of a prospective dose escalation phase-II trial: Interstitial pulsed-dose-rate brachytherapy as boost for intermediate- and high-risk prostate cancer
Sebastian Lettmaier et al.
RADIOTHERAPY AND ONCOLOGY (2012)
Comparison of Health-Related Quality of Life 5 Years After SPIRIT: Surgical Prostatectomy Versus Interstitial Radiation Intervention Trial
Juanita Mary Crook et al.
JOURNAL OF CLINICAL ONCOLOGY (2011)
Review of intraoperative imaging and planning techniques in permanent seed prostate brachytherapy
Alfredo Polo et al.
RADIOTHERAPY AND ONCOLOGY (2010)
Critical discussion of different dose-volume parameters for rectum and urethra in prostate brachytherapy
Christian Kirisits et al.
BRACHYTHERAPY (2009)
Phantom investigations on CT seed imaging for interstitial brachytherapy
Frank-Andre Siebert et al.
RADIOTHERAPY AND ONCOLOGY (2007)
Tumour and target volumes in permanent prostate brachytherapy: A supplement to the ESTRO/EAU/EORTC recommendations on prostate brachytherapy
Car Salembier et al.
RADIOTHERAPY AND ONCOLOGY (2007)
Biologically effective dose values for prostate brachytherapy: Effects on PSA failure and posttreatment biopsy results
RG Stock et al.
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS (2006)
Randomized trial comparing iridium implant plus external-beam radiation therapy with external-beam radiation therapy alone in node-negative locally advanced cancer of the prostate
JR Sathya et al.
JOURNAL OF CLINICAL ONCOLOGY (2005)
High dose rate afterloading brachytherapy for prostate cancer: catheter and gland movement between fractions
PJ Hoskin et al.
RADIOTHERAPY AND ONCOLOGY (2003)
ESTRO/EAU/EORTC recommendations on permanent seed implantation for localized prostate cancer
D Ash et al.
RADIOTHERAPY AND ONCOLOGY (2000)